The World Health Organization (WHO) estimates that up to 900 million worldwide could be affected by disabling SNHL by 2050. Image credit: Janeberry via Shutterstock.com. The US Food and Drug ...
DURHAM, N.C.--(BUSINESS WIRE)--Hearing implant leader MED-EL Corporation announced today the U.S. Food and Drug Administration (FDA) approval of new indications along with the first-ever approval of ...
DURHAM, N.C.--(BUSINESS WIRE)--MED-EL USA announced today that the U.S. Food and Drug Administration approved the new SONNET 3 audio processor for MED-EL cochlear implants. SONNET 3 is the company’s ...
Add Yahoo as a preferred source to see more of our stories on Google. DuJuan Broadus Jr, 10, is a Louisville boy has received hearing care from UK HealthCare's Ear, Nose and Throat clinic with his ...
First and Only Cochlear Implant FDA Approved for Youngest Infant Population MED-EL USA announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for MED-EL ...
LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
The US Food and Drug Administration (FDA) has approved an expanded indication for MED-EL’s SYNCHRONY cochlea implants in infants aged seven months and older with bilateral sensorineural hearing loss ...
A Louisville boy recently became the first patient in the United States to receive a MED-EL FLEX34 cochlear implant, which is designed for people with an unusually large cochlea — the part of the ear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results